Docket #: S19-552
Collagen-Based Hydrogels for Cell and Growth Factor Delivery
Collagen-based hydrogels behave similarly to the native tissue microenvironment, thus are widely used as scaffolds for encapsulating cells or molecules like growth factors. Collagen solution is an injectable liquid until it crosslinks at 37 C and physiological pH. However, dilution or leakage of the hydrogel once injected into the body can be problematic for regenerative medicine applications. Moreover, low viscosity and structural instability can limit its use as a bioink in 3D bioprinting. To improve the viscosity, stability, and mechanical properties of the collagen matrix, the inventors incorporated alginate and calcium sulfate (CaSO4). This novel alg/col hydrogel is shear-thinning and injectable through commercially available needles. The storage modulus and viscosity of these hydrogels can be tuned by altering the collagen content or CaSO4. Human mesenchymal stem cells (hMSCs) have >90% post-injection viability over 7 days and significant proliferative capacity. The encapsulated stem cells are functional and retain the ability to differentiate.
Applications
- Delivery of cells and/or growth factors for regenerative medicine purposes, including:
- Minimally-invasive surgeries
- Treating rotator-cuff injury using athroscopy
- Treating osteonecrosis
- As a bioink in 3D bioprinting of cellular constructs
Advantages
- Injectable through commercially available needles
- Highly stable and resistant to dilution or leakage
- Compared to pure alginate hydrogel, alg/col hydrogel has improved biocompatibility, cell-interactive ligands, and bioresorbability
- Preparation of the hydrogel does not require specific processing steps or instrument
- Precursor solutions of the alg/col hydrogel can be stored, mixed with patient cells, and used in the operation room
Publications
- Moeinzadeh, SM., et al. In-situ stable injectable collagen-based hydrogels for cell and growth factor delivery. Materialia 2021; 15: 100954
- Park, Youngbum, et al. "Dual delivery of BMP-2 and IGF-1 through injectable hydrogel promotes cranial bone defect healing." Tissue Engineering ja (2022).
Related Links
Patents
- Published Application: 20220054639
- Issued: 12133893 (USA)
Similar Technologies
-
AN OXYGEN-GENERATING COLLAGEN-BASED CRYOGEL BIOSCAFFOLD FOR PANCREATIC ISLET TRANSPLANTATION S18-259AN OXYGEN-GENERATING COLLAGEN-BASED CRYOGEL BIOSCAFFOLD FOR PANCREATIC ISLET TRANSPLANTATION
-
Drug-imprinted hydrogel for controlled-release wound healing therapy with FAK inhibitors S14-447Drug-imprinted hydrogel for controlled-release wound healing therapy with FAK inhibitors
-
Gel scaffold for corneal wound healing and tissue engineering S18-196Gel scaffold for corneal wound healing and tissue engineering